| PERIOD ENDING | 31-Dec-08 | 31-Dec-07 | 31-Dec-06 | | Total Revenue | 11,085,000 | 9,408,000 | 8,408,000 | | Cost of Revenue | 5,117,000 | 4,531,000 | 4,149,000 | | | Gross Profit | 5,968,000 | 4,877,000 | 4,259,000 | | | Operating Expenses | | Research Development | 786,000 | 581,000 | 495,000 | | Selling General and Administrative | 2,511,000 | 1,901,000 | 1,572,000 | | Non Recurring | 1,526,000 |
-
| 1,391,000 | | Others |
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | 1,145,000 | 2,395,000 | 801,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (144,000) | (42,000) | 84,000 | | Earnings Before Interest And Taxes | 1,001,000 | 2,353,000 | 885,000 | | Interest Expense | 174,000 |
-
| 179,000 | | Income Before Tax | 827,000 | 2,353,000 | 706,000 | | Income Tax Expense | 185,000 | 397,000 | 155,000 | | Minority Interest | (6,000) | (1,000) | (2,000) | | | | Net Income From Continuing Ops | 635,000 | 1,952,000 | 546,000 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | 635,000 | 1,952,000 | 546,000 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $635,000 | $1,952,000 | $546,000 |
|
0.49% Nasdaq 
Income Statement
